120 related articles for article (PubMed ID: 9024331)
1. Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.
Small GW
J Clin Psychiatry; 1996; 57 Suppl 14():9-13. PubMed ID: 9024331
[TBL] [Abstract][Full Text] [Related]
2. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging.
Small GW; Komo S; La Rue A; Saxena S; Phelps ME; Mazziotta JC; Saunders AM; Haines JL; Pericak-Vance MA; Roses AD
Ann N Y Acad Sci; 1996 Dec; 802():70-8. PubMed ID: 8993486
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
4. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
[TBL] [Abstract][Full Text] [Related]
6. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging for diagnosis of dementia.
Small GW; Leiter F
J Clin Psychiatry; 1998; 59 Suppl 11():4-7. PubMed ID: 9731543
[TBL] [Abstract][Full Text] [Related]
8. Early detection of Alzheimer's disease using neuroimaging.
Mosconi L; Brys M; Glodzik-Sobanska L; De Santi S; Rusinek H; de Leon MJ
Exp Gerontol; 2007; 42(1-2):129-38. PubMed ID: 16839732
[TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.
Small GW; Ercoli LM; Silverman DH; Huang SC; Komo S; Bookheimer SY; Lavretsky H; Miller K; Siddarth P; Rasgon NL; Mazziotta JC; Saxena S; Wu HM; Mega MS; Cummings JL; Saunders AM; Pericak-Vance MA; Roses AD; Barrio JR; Phelps ME
Proc Natl Acad Sci U S A; 2000 May; 97(11):6037-42. PubMed ID: 10811879
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
11. Brain-imaging surrogate markers for detection and prevention of age-related memory loss.
Small GW
J Mol Neurosci; 2002; 19(1-2):17-21. PubMed ID: 12212776
[TBL] [Abstract][Full Text] [Related]
12. "Cognitive stress test" may yield early clues of preclinical AD.
Hotz RL
Am J Alzheimers Dis Other Demen; 2001; 16(1):9-10. PubMed ID: 11416956
[No Abstract] [Full Text] [Related]
13. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C
Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150
[TBL] [Abstract][Full Text] [Related]
15. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
Reinvang I; Espeseth T; Westlye LT
Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
[TBL] [Abstract][Full Text] [Related]
17. Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease.
Lucotte G; Aouizérate A; Gérard N; Turpin JC; Landais P
Am J Med Genet; 1995 Dec; 60(6):566-9. PubMed ID: 8825898
[TBL] [Abstract][Full Text] [Related]
18. Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.
Small GW
Adv Drug Deliv Rev; 2002 Dec; 54(12):1561-6. PubMed ID: 12453673
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases.
Locke PA; Conneally PM; Tanzi RE; Gusella JF; Haines JL
Genet Epidemiol; 1995; 12(1):83-92. PubMed ID: 7713402
[TBL] [Abstract][Full Text] [Related]
20. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8299-302. PubMed ID: 15932949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
